Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expenses from patients in its ...
In its fourth quarter 2024 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV) in the fourth quarter 2024 investor letter. Elevance Health ...
Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a spokesperson for Elevance confirmed to Fierce Healthcare. Further details about ...
Elevance Health stock opened at $385.52 on Thursday. The stock has a market cap of $89.41 billion, a PE ratio of 15.05, a P/E/G ratio of 1.17 and a beta of 0.83. The stock has a 50-day moving ...
Before making this announcement, Elevance Health was easily earning enough to cover the dividend. As a result, a large proportion of what it earned was being reinvested back into the business.
Elevance Health said Thursday it expects cost pressures on its Medicaid business to ease by midyear. That could spell good news for other Medicaid players as well. Medicaid managed care ...
Financial giants have made a conspicuous bullish move on Elevance Health. Our analysis of options history for Elevance Health ELV revealed 12 unusual trades. Delving into the details, we found 50% ...
CVS Health's MinuteClinic and Georgia-based Emory Healthcare are expanding their partnership to provide in-network primary ...
We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best ...
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday.
Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target is $463.00. Whit Mayo has given his Buy rating due ...
Piotr Swat / SOPA Images / LightRocket via Getty Images Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results